A phase 1 dose-escalation study of intravenous MST-997 formulated in polysorbate 80 diluent administered weekly in subjects with advanced malignant solid tumors
Latest Information Update: 23 Jan 2007
At a glance
- Drugs Simotaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Wyeth
- 09 Dec 2006 Status change
- 27 Jul 2006 New trial record.